Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
Clinical trial NCT02636582 · COMPLETED
Trial details
- NCT number
- NCT02636582
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-14
- Primary completion
- 2019-07-22
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.